Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | HPGD | P15428 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | BLM | P54132 | 1/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.78 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 2/20 | 0.40 |
| ▸ | ENO1 | P06733 | 1/20 | 0.40 |
| ▸ | PGK1 | P00558 | 1/20 | 0.39 |
| ▸ | PGK2 | P07205 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fosfonet SCHEMBL25402251 | 0.89 | MEN1 (0.78) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL9377672 | 0.89 | MEN1 (0.61) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL15612 | 0.88 | — | — | |
| Fosfonet SCHEMBL347045 | 0.86 | MEN1 (0.82) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL4607410 | 0.85 | MEN1 (0.93) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL9162319 | 0.85 | — | — | |
| Fosfonet SCHEMBL2801407 | 0.85 | — | — | |
| Fosfonet SCHEMBL11026013 | 0.85 | — | — | |
| Fosfonet SCHEMBL15510455 | 0.85 | MEN1 (0.93) | MEN1LMNAHPGDTSHRBLM | |
| Fosfonet SCHEMBL28151124 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023207268-A1 | SYNTHESIS METHOD OF PLANT-DERIVED DEOXYCHOLIC ACID | 上海科骊科生物技术有限公司 | 2023-11-02 | — | — | WO | claimed |
| CN-115536719-A | Synthetic method of high-purity plant source 7-ketolithocholic acid | 江苏佳尔科药业集团股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-113354954-B | Cationic photocuring epoxy vegetable oil-based flame-retardant material and preparation method and application thereof | 华南农业大学 | 2022-04-26 | — | — | CN | claimed |
| CN-113354954-A | Cationic photocuring epoxy vegetable oil-based flame-retardant material and preparation method and application thereof | 华南农业大学 | 2021-09-07 | — | — | CN | claimed |
| WO-2021109791-A1 | METHOD FOR SYNTHESIZING URSODEOXYCHOLIC ACID USING BA AS RAW MATERIAL | 江苏佳尔科药业集团股份有限公司 | 2021-06-10 | — | — | WO | claimed |
| CN-104529800-A | Preparation method of trans-4-dimethylaminocrotonic acid and its salt | CHONGQING WEIPENG PHARMACEUTICAL CO LTD | 2015-04-22 | — | — | CN | claimed |
| CN-1867564-B | Process for producing amino crotonyl compound | BOEHRINGER INGELHEIM INT | 2011-06-08 | — | — | CN | claimed |
| CN-1867564-A | Process for producing amino crotonyl compound | BOEHRINGER INGELHEIM INT (DE) | 2006-11-22 | — | — | CN | claimed |
| JP-5331093-A | — | — | None | — | — | JP | disclosed |
| US-12441759-B2 | Method for synthesizing ursodeoxycholic acid using BA as raw material | JIANGSU JIAERKE PHARMACEUTICALS GROUP CORP., LTD. (CN) | 2025-10-14 | — | — | US | disclosed |
| US-12415789-B2 | Macrocycles comprising a 4-amido-2,4-pentadienoate moiety for the treatment of hypoxic cancers | AARHUS UNIVERSITET (DK) | 2025-09-16 | — | — | US | disclosed |
| CN-120119112-A | Method for recovering aluminum matrix from aluminum target containing indium-tin solder | 新疆众和股份有限公司 | 2025-06-10 | — | — | CN | disclosed |
| US-12233081-B2 | Hygromycin a compounds and methods of treating spirochete diseases | NORTHEASTERN UNIVERSITY (US) | 2025-02-25 | — | — | US | disclosed |
| CN-119340518-A | Lithium secondary battery and assembly | 大金工业株式会社 | 2025-01-21 | — | — | CN | disclosed |
| JP-H05331093-A | INTERMEDIATE FOR 1,25-DIHYDROXYVITAMIN D3 | TAISHO PHARMACEUT CO LTD | 1993-12-14 | — | — | JP | disclosed |
| EP-0454494-A2 | Calicheamicinone, derivatives and analogs thereof and methods of making the same | YALE UNIVERSITY (US) | 1991-10-30 | — | — | EP | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |
| EP-0330939-A2 | Acrylic acid morpholides, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1989-09-06 | — | — | EP | disclosed |
| EP-0199618-A1 | 5-H-pyrido[3',4':4,5]pyrrolo[3,2-c]pyridones, process for their preparation and their use as intermediate synthesis compounds | SANOFI (FR) | 1986-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12233081-B2 | Hygromycin a compounds and methods of treating spirochete diseases | TREH, GBA1, HSP90AB1 | MEN1 409/4885LMNA 604/4885HPGD 902/4885 |
| US-12441759-B2 | Method for synthesizing ursodeoxycholic acid using BA as raw material | CYP7A1, DHCR7, CYP46A1 | MEN1 3844/4885LMNA 2312/4885HPGD 347/4885 |
| US-12415789-B2 | Macrocycles comprising a 4-amido-2,4-pentadienoate moiety for the treatment of hypoxic cancers | DLD, HIF1A, DPYD | MEN1 3400/4885LMNA 4294/4885HPGD 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.